Azerbaijani pharmaceuticals to be exported to Middle East, Gulf and African countries

Pharmaceuticals produced in Azerbaijan are planned to be exported to Saudi Arabia, as well as the Middle East, the Gulf and African countries, the Small and Medium Business Development Agency (KOBIA) under the Ministry of Economy told Report.

During the 6th meeting of the Azerbaijan-Saudi Arabia Joint Business Council held in Riyadh in April 2025, several important documents were signed: "Thus, a Memorandum of Understanding (MoU) in the pharmaceutical industry was concluded between Azerbaijan's Parla Pharmaceuticals company and Saudi Arabia's National Development Group Holding company.

According to the MoU, medicines produced in Azerbaijan are planned to be exported to Saudi Arabia, as well as the Middle East, Gulf and African countries."

The next stage envisions the transfer of scientific and technological knowledge and the establishment of a joint pharmaceutical manufacturing enterprise in Saudi Arabia. This is considered to be of strategic importance in terms of strengthening Azerbaijan's export potential in the pharmaceutical industry.

In addition, during the meeting, an agreement on cooperation in the field of maritime infrastructure was signed between Azerbaijan's ADO-G and Saudi Arabia's SMI/BLUE MASAR companies.

KOBIA evaluates these collaborations as an important step in terms of expanding local small and medium-sized enterprises' (SMEs) access to foreign markets and accelerating their international integration.

As part of the cooperation between Azerbaijan and Saudi Arabia, the 7th meeting of the Joint Commission between the governments of the two countries was held in Baku on December 19, 2022.

During the meeting, an agreement on the establishment of the Azerbaijan-Saudi Arabia Joint Business Council was signed between KOBIA and the Federation of Saudi Chambers.